These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29519261)

  • 1. [EndoBarrier as a treatment for obesity and diabetes].
    Greve JWM; Bouvy ND
    Ned Tijdschr Geneeskd; 2018; 162():D2268. PubMed ID: 29519261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
    Patel N; Mohanaruban A; Ashrafian H; Le Roux C; Byrne J; Mason J; Hopkins J; Kelly J; Teare J
    Obes Surg; 2018 Jul; 28(7):1980-1989. PubMed ID: 29450844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.
    Betzel B; Cooiman MI; Aarts EO; Janssen IMC; Wahab PJ; Groenen MJM; Drenth JPH; Berends FJ
    Surg Endosc; 2020 Jan; 34(1):209-215. PubMed ID: 30877567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EndoBarrier for counteracting obesity and metabolic syndrome].
    Verdam FJ; Liedorp PR; Geubbels N; Schouten R; Janssen IM; Koek GH; Greve JW
    Ned Tijdschr Geneeskd; 2012; 156(13):A3844. PubMed ID: 22456287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.
    Glaysher MA; Mohanaruban A; Prechtl CG; Goldstone AP; Miras AD; Lord J; Chhina N; Falaschetti E; Johnson NA; Al-Najim W; Smith C; Li JV; Patel M; Ahmed AR; Moore M; Poulter N; Bloom S; Darzi A; Le Roux C; Byrne JP; Teare JP
    BMJ Open; 2017 Nov; 7(11):e018598. PubMed ID: 29146657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pancreatitis as an adverse event in patients with the duodenal-jejunal bypass liner.
    Betzel B; Homan J; Aarts E; Janssen I; Spanier M; Wahab P; Groenen M; Berends F
    Endoscopy; 2015 Nov; 47(11):1050-3. PubMed ID: 26021308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity.
    Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ
    Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is reimplantation of the duodenal-jejunal bypass liner feasible?
    Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
    Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes.
    Levine A; Ramos A; Escalona A; Rodriguez L; Greve JW; Janssen I; Rothstein R; Nepomnayshy D; Gersin KS; Melanson D; Lamport R; Fishman E; Malomo K; Kaplan LM; Neto MG
    Surg Obes Relat Dis; 2009; 5(3):371-4. PubMed ID: 19460677
    [No Abstract]   [Full Text] [Related]  

  • 10. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
    Patel SR; Hakim D; Mason J; Hakim N
    Surg Obes Relat Dis; 2013; 9(3):482-4. PubMed ID: 23452926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
    Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
    Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner.
    Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
    Surg Obes Relat Dis; 2018 Jun; 14(6):769-779. PubMed ID: 29650340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of duodenal-jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta-analysis.
    Chen W; Feng J; Dong S; Guo J; Zhou F; Hu S; Hu R; Wang C; Ma Y; Dong Z
    Obes Rev; 2024 Nov; 25(11):e13812. PubMed ID: 39191438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review.
    Betzel B; Drenth JPH; Siersema PD
    Obes Surg; 2018 Nov; 28(11):3669-3677. PubMed ID: 30121857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical steps for removal of duodenojejunal bypass liner (endobarrier device).
    Soares RV; Perretta S; Ignat DM; Vix M; Swanstrom LL
    Gastrointest Endosc; 2016 Dec; 84(6):1063. PubMed ID: 27311653
    [No Abstract]   [Full Text] [Related]  

  • 16. The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review.
    Zechmeister-Koss I; Huić M; Fischer S;
    Obes Surg; 2014 Feb; 24(2):310-23. PubMed ID: 24293185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal-jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3-year outcomes in the First National Health Service (NHS) EndoBarrier Service.
    Ryder REJ; Yadagiri M; Burbridge W; Irwin SP; Gandhi H; Bashir T; Allden RA; Wyres M; Cull M; Bleasdale JP; Fogden EN; Anderson MR; Sen Gupta P
    Diabet Med; 2022 Jul; 39(7):e14827. PubMed ID: 35285080
    [No Abstract]   [Full Text] [Related]  

  • 18. Sleeve gastrectomy with duodenojejunal end-to-side anastomosis in the treatment of type 2 diabetes: the initial experiences in a Chinese population with a more than 4-year follow-up.
    Ruan X; Zhang W; Cai H; Zheng R; Jiang F; Zhu H
    Surg Obes Relat Dis; 2017 Oct; 13(10):1683-1691. PubMed ID: 28780045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic Bypass Using Endobarrier Devices: Efficacy in Treating Obesity and Metabolic Syndrome.
    Jain D; Singhal S
    J Clin Gastroenterol; 2015; 49(10):799-803. PubMed ID: 26302497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative metabolic operations.
    Cohen R; Caravatto PP; Petry TZ
    Surg Obes Relat Dis; 2016 Jul; 12(6):1247-55. PubMed ID: 27317607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.